Tumor immune microenvironment alterations using induction cetuximab in a phase II trial of deintensified therapy for p16-positive oropharynx cancer.
Saved in:
| Title: | Tumor immune microenvironment alterations using induction cetuximab in a phase II trial of deintensified therapy for p16-positive oropharynx cancer. |
|---|---|
| Authors: | Smith JD; Department of Otolaryngology - Head & Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA., Ludwig ML; Department of Otolaryngology - Head & Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA., Bhangale AD; Department of Otolaryngology - Head & Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA., Brummel C; Department of Otolaryngology - Head & Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA., Swiecicki PL; Division of Hematology & Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA., Worden FP; Division of Hematology & Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA., Chinn SB; Department of Otolaryngology - Head & Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA., Stucken CL; Department of Otolaryngology - Head & Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA., Rosko AJ; Department of Otolaryngology - Head & Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA., Prince MEP; Department of Otolaryngology - Head & Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA., Malloy KM; Department of Otolaryngology - Head & Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA., Casper KA; Department of Otolaryngology - Head & Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA., Bradford CR; Department of Otolaryngology - Head & Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA., Chepeha DB; Department of Otolaryngology - Head & Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA., Shah J; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan, USA., Schonewolf CA; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan, USA., McHugh JB; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA., Nyati MK; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan, USA., Eisbruch A; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan, USA., Mierzwa ML; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan, USA., Spector ME; Department of Otolaryngology - Head & Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA., Brenner JC; Department of Otolaryngology - Head & Neck Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA. |
| Source: | Head & neck [Head Neck] 2023 May; Vol. 45 (5), pp. 1281-1287. Date of Electronic Publication: 2023 Mar 18. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley And Sons Country of Publication: United States NLM ID: 8902541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0347 (Electronic) Linking ISSN: 10433074 NLM ISO Abbreviation: Head Neck Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0347 |
|---|---|
| DOI: | 10.1002/hed.27344 |
